Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: Promising anticancer agents

被引:190
|
作者
Aboraia, AS [1 ]
Abdel-Rahman, HM [1 ]
Mahfouz, NM [1 ]
El-Gendy, MA [1 ]
机构
[1] Assiut Univ, Fac Pharm, Pharmaceut Med Chem Dept, Assiut 71526, Egypt
关键词
anticancer activity; 1,3,4-oxadiazoles; Mannich basest; salicylate analogs;
D O I
10.1016/j.bmc.2005.09.053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 5-(2-hydroxyphenyl)-3-susstituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives was synthesized and 13 of them were selected by the National Cancer Institute (NCl) and evaluated for their in vitro anticancer activity. Seven of the investigated compounds, 3i, 3j, 3k, 3o, 3p, 3q, and 3r, displayed high anticancer activity in the primary assay. These compounds have been selected for a full anticancer screening against a 60-cell panel assay where they showed non-selective broad spectrum and promising activity against all cancer cell lines. Compounds 3j and 3k proved to be the active members in this Study compared to 5-fluorouracil and cyclophosphamide as reference drugs, respectively. Compounds 3j and 3k were identified as promising lead compounds. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1236 / 1246
页数:11
相关论文
共 50 条
  • [1] 5-(Adamantan-1-yl)-3-anilinomethyl-2,3-dihydro-1,3,4-oxadiazole-2-thione
    Al-Tamimi, Abdul-Malek S.
    Al-Deeb, Omar A.
    El-Emam, Ali A.
    Ng, Seik Weng
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O729 - +
  • [2] 5-(Adamantan-1-yl)-3-[(4-fluoroanilino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione
    Al-Tamimi, Abdul-Malek S.
    Alafeefy, Ahmed M.
    El-Emam, Ali A.
    Ng, Seik Weng
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O730 - +
  • [3] 3-[(4-Phenylpiperazin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazole-2-thione
    El-Emam, Ali A.
    Al-Omar, Mohamed A.
    Al-Obaid, Abdul-Rahman M.
    Ng, Seik Weng
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O684 - +
  • [4] METAL-COMPLEXES OF 5-(ORTHO)HYDROXYPHENYL-1,3,4-OXADIAZOLE-2-THIONE
    LAKSHMI
    RAI, RA
    JOURNAL OF INORGANIC & NUCLEAR CHEMISTRY, 1980, 42 (03): : 450 - 453
  • [5] 5-(3-Pyridyl)-1,3,4-oxadiazole-2-thione
    Wang, Yong-Tao
    Qiang, Zhen-Wei
    Wan, Wen-Zhu
    Tang, Gui-Mei
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O5585 - O5586
  • [6] Crystal structure of 3-[(4-benzylpiperazin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazole-2-thione
    Al-Omary, Fatmah A. M.
    El-Emam, Ali A.
    Ghabbour, Hazem A.
    Kumar, C. S. Chidan
    Quah, Ching Kheng
    Fun, Hoong-Kun
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2015, 71 : O175 - +
  • [7] 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities
    Abdel-Aziz, Mohamed
    Metwally, Kamel A.
    Gamal-Eldeen, Amira M.
    Aly, Omar M.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (02) : 269 - 277
  • [8] Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents
    Bajaj, Shalini
    Roy, Partha Pratim
    Singh, Jagadish
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2018, 76 : 151 - 160
  • [9] Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents
    Chaves, Joana Darc S.
    Tunes, Luiza Guimaraes
    Franco, Chris Hebert de J.
    Francisco, Thiago Martins
    Correa, Charlane Cimini
    Murta, Silvane M. F.
    Monte-Neto, Rubens Lima
    Silva, Heveline
    Fontes, Ana Paula S.
    de Almeida, Mauro V.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 727 - 739
  • [10] Synthesis and Biological Activities of Some Mannich Bases of 5-(4-Hydroxyphenyl)-1,3,4-Oxadiazole-2-Thione
    庞华
    张君仁
    帅翔
    王建河
    JournalofChinesePharmaceuticalSciences, 1998, (02) : 54 - 55